Jim Simons Y M Abs Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 115,300 shares of YMAB stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,300

Previous 174,800 34.04%

Holding current value

$1.4 Million

Previous $1.19 Million 57.3%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.57 - $18.69 $390,915 - $1.11 Million	-59,500 Reduced 34.04%	115,300 $1.88 Million
Q4 2023 Feb 13, 2024	SELL	$4.88 - $7.42 $303,975 - $462,191	-62,290 Reduced 26.27%	174,800 $1.19 Million
Q3 2023 Nov 14, 2023	BUY	$4.86 - $7.23 $101,525 - $151,034	20,890 Added 9.66%	237,090 $1.29 Million
Q2 2023 Aug 11, 2023	BUY	$5.68 - $10.34 $731,584 - $1.33 Million	128,800 Added 147.37%	216,200 $1.47 Million
Q1 2023 May 12, 2023	BUY	$2.83 - $5.11 $95,937 - $173,229	33,900 Added 63.36%	87,400 $438,000

Q4 2022 Feb 13, 2023	SELL	$3.0 - $15.17 $223,200 - $1.13 Million	-74,400 Reduced 58.17%	53,500 $261,000
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $305,724 - $430,773	-21,900 Reduced 14.62%	127,900 $1.84 Million
Q2 2022 Aug 12, 2022	BUY	$8.22 - $15.13 $483,336 - $889,644	58,800 Added 64.62%	149,800 $2.27 Million
Q1 2022 May 13, 2022	SELL	$6.55 - $17.42 $49,780 - $132,392	-7,600 Reduced 7.71%	91,000 $1.08 Million
Q4 2021 Feb 11, 2022	BUY	$15.51 - $29.31 $1.53 Million - $2.89 Million	98,600 New	98,600 $1.6 Million
Q2 2021 Aug 13, 2021	SELL	$25.45 - $37.64 $819,490 - $1.21 Million	-32,200 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$29.16 - $51.96 $938,952 - $1.67 Million	32,200 New	32,200 $974,000
Q1 2020 May 14, 2020	SELL	$14.39 - $35.8 $374,140 - $930,799	-26,000 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$23.81 - $33.78 $1.06 Million - $1.51 Million	-44,700 Reduced 63.22%	26,000 $813,000
Q3 2019 Nov 13, 2019	BUY	$21.57 - $31.37 $623,373 - $906,593	28,900 Added 69.14%	70,700 $1.84 Million
Q2 2019 Aug 12, 2019	BUY	$19.51 - $28.31 $815,518 - $1.18 Million	41,800 New	41,800 $956,000

Others Institutions Holding YMAB

# of Institutions

Shares Held

22.4M

Call Options Held

37.4K

Put Options Held

48.2K

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $529M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account